Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 60 and up

Dexmedetomidine's effects on blood pressure during intubation in hypertensive patients

Official title: Title: the Effects of Dexmedetomidine on Hemodynamic Responses to Endotracheal Intubation in Hypertensive Patients Undergoing Surgery

Run by Liaquat National Hospital & Medical College · NCT06712186 · Data updated 2026-11-12

This study tests if giving dexmedetomidine can help lower blood pressure and anxiety in older patients with high blood pressure during intubation for surgery.

More Blood Pressure trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages60 Years and up
SexAll
Enrollment60 (estimated)
SponsorLiaquat National Hospital & Medical College
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedJune 22, 2024
Main results expectedNovember 22, 2024
Study endsDecember 1, 2024
Registry record updatedDecember 11, 2024
Trial IDNCT06712186 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are hypertensive patients over 60 years old undergoing elective surgical procedures under general anesthesia.

Probably not a fit

Patients with uncontrolled hypertension or those requiring emergency surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of dexmedetomidine, an alpha-2 adrenergic agonist, on the hemodynamic responses of hypertensive patients undergoing endotracheal intubation. The study aims to assess how dexmedetomidine can reduce anxiety, improve intubating conditions, and attenuate hemodynamic responses such as tachycardia and hypertension during the procedure. Participants will be divided into two groups: one receiving dexmedetomidine and the other receiving a placebo. The trial will focus on patients aged over 60 with a history of hypertension who are scheduled for elective surgeries under general anesthesia.

Why it matters

Potential benefit: If successful, this study could lead to safer intubation practices for hypertensive patients, reducing the risk of serious complications.

How similar studies have gone: Other studies have shown promising results with dexmedetomidine in similar contexts, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ASA Grade II
* Age \> 60 years
* Elective surgical procedures under GA.
* All patients with a diagnosis of hypertension for 6 months or more and undergoing treatment with antihypertensive medications.

Exclusion Criteria:

* Patient refusal
* ASA Grade III and IV
* Severely Hypovolemic state
* Emergency surgeries
* Body weight more than 20% of ideal body weight.
* Patients with known or unanticipated difficult intubation and those requiring more than 15 sec or two attempts at laryngoscopy
* Allergic to dexmedetomidine
* Non complaint hypertensive patients
* Patients with uncontrolled hypertension.

Where it's running

  • Liaquat National Hospital and Medical College
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Warisha ismail Dr Warisha ismail — Liaquat National Hospital and Medical College
  • Study coordinator: Warisha Ismail Dr Warisha Ismail
  • Email: khanveera97@gmail.com
  • Phone: +92 3046878028

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.